 |
Click here for
NJ Preventive Cardiology practice brochure
|
Mentoring Program |
|
For Physicians:
Practical Tips for
Clinicians

For Communities:
Heart2Heart Talk

For Employers and Employees:
You and Health Reform

|
|
|
 |
|  | 
http://www.cdc.gov/Features/millionhearts/
Heart disease constitutes 17% of the overall national health spending. The country can no longer afford to spend this large sum of money that it does not have, on heart disease that is now considered largely preventable. 
The above slide demonstrates why cardiovascular disease consumes a tremendous amount of healthcare dollars - its natural course is one of silent progression and recurring cardiovascular events - heart attacks and strokes. The treatments of very advanced disease - hospitalizations, stents, heart bypass, are very expensive. For over a decade now, optimal medical therapy using inexpensive generic medications, has been available to prevent or delay most of these events.

The above slide calculates how many lives could be saved if just 60% of high risk (those with 10 Year Framingham Risk Score of over 20%) adult Americans received optimal medical therapy for their risk factors. It also compares the magnitude of mortality reduction with primary and secondary prevention (optimal medical therapy) compared to more expensive stents and heart bypass. Practical Tips and Clinical Tools for Primary Care Physicians... Being developed.
|  |
|
Emil M. deGoma, MD, FACC
Medical Director,
UPenn Preventive
Cardiovascular Program
|
Health Premium Discount |
Lower your risk for heart attack and stroke
using evidence-based therapies and become
eligible for a substantial premium discount by
2014.
 |
|
 |
|
|
Health Reform 2010 |
Prevention and Wellness Summary Provisions
 |
|
 |
|
|
Relay Health |
Contact Office for Non-Urgent Matters
 |
|
 |
|
We Support
Million Hearts Initiative
497,470 Preventable CHD Deaths
Annually with
Evidence-based Medical Therapy
JAMA: 38% of Nonacute
Stents Called into Question
Optimal Medical Therapy Still Underused in
CHD
Legacy Effects
of Statin Therapy - Reduction in
All-Cause Mortality
SG2 Expert Talks About Resetting
Priorities in Cardiology
AHA: Get With The Guidelines - Not Much
Improvement
AIM-HIGH Trial -
Take Home
Message
|